| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |